Biological evaluation of twenty-eight ferrocenyl tetrasubstituted olefins: Cancer cell growth inhibition, ROS production and hemolytic activity - Archive ouverte HAL Access content directly
Journal Articles European Journal of Medicinal Chemistry Year : 2011

Biological evaluation of twenty-eight ferrocenyl tetrasubstituted olefins: Cancer cell growth inhibition, ROS production and hemolytic activity

Abstract

The antiproliferative effects of twenty-eight tetrasubstituted olefins bearing a ferrocenyl group, including six never-reported compounds, were evaluated against SF-295 (human glioblastoma), HCT-8 (human colon cancer), MDA-MB-435 (human melanoma) and HL-60 (human promyelocytic leukemia) using the MTT test. IC(50) values were determined for twenty-three active compounds and of these, ten compounds had IC(50) values lower than 2 mu M on one or more cell lines. Of all the compounds, only two produced significant amounts of ROS on HL-60 cells, and ROS production and growth inhibition could not be correlated. The ten most antiproliferative compounds were tested for their hemolytic activity on mouse erythrocytes. Five compounds showing high antiproliferative activity and low hemolytic activity were thus identified for further study.
Fichier principal
Vignette du fichier
Biological evaluation of twenty.pdf (1.36 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-01230389 , version 1 (17-04-2024)

Identifiers

Cite

Alane Cabral De Oliveira, Elisabeth A. Hillard, Pascal Pigeon, Danilo Damasceno Rocha, Felipe A. R. Rodrigues, et al.. Biological evaluation of twenty-eight ferrocenyl tetrasubstituted olefins: Cancer cell growth inhibition, ROS production and hemolytic activity. European Journal of Medicinal Chemistry, 2011, 46 (9), pp.3778-3787. ⟨10.1016/j.ejmech.2011.05.043⟩. ⟨hal-01230389⟩
92 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More